Scientists used CRISPR tech to create a custom-made drug targeted at helping a newborn baby fight a rare genetic disorder. According to an extraordinary new paper published in The New England Journal of Medicine, the drug worked — marking the first time that a patient was successfully healed with a bespoke gene-hacked medicine, and a possible watershed moment for the field of genetic medicine. The baby, named KJ Muldoon, was born at the Children's Hospital of Philadelphia (CHOP) and at Penn Medicine with a rare genetic condition called CPS1 deficiency. According to the National Institutes of Health (NIH), the condition […]